nvestigation of Synergistic, Additive and Antagonist Effect of Antimicrobial Combinations Used for Brucella spp, with E-test Combination Method

dc.contributor.authorKaysadu, Halim
dc.contributor.authorDuman, Yücel
dc.contributor.authorYakupoğulları, Yusuf
dc.date.accessioned2020-12-29T09:08:01Z
dc.date.available2020-12-29T09:08:01Z
dc.date.issued2019
dc.departmentİnönü Üniversitesien_US
dc.descriptionYıl: 2019Cilt: 24Sayı: 1ISSN: 1301-0883 / 1339-3886Sayfa Aralığı: 95 - 101Metin Dili:İngilizceen_US
dc.description.abstractÖz: Brucella spp. is a significant cause of morbidity and mortality in human. Though combination therapy is recommended in the patients with brucellosis, there is very less data about the in vitro efficacy of the combined antimicrobials. In this study, we aimed to investigate the in vitro activities of antimicrobial combinations used against the Brucella spp. strains. A total 40 human isolates of Brucella spp. strains were included in this study. In vitro activities of doxycycline, rifampin, cotrimoxazole, streptomycin and ciprofloxacin were studied by E-test (Bio Mérieux, France) strips. In vitro effectiveness of doxycycline-rifampin, rifampin-cotrimoxazole, doxycycline-streptomycin, ciprofloxacin-cotrimoxazole, and ciprofloxacin-streptomycin were investigated by E-test combination method, and the results were evaluated with Fractional Inhibitor Concentration Index. Cotrimoxazole was found as the most active antimicrobial against to tested Brucella isolates with the lowest Minimal Inhibitory Concentration (MIC) (as, 0.016 µg/ml), while rifampin was the least active drug with highest MIC (as 1.5 µg/ml). The MIC50 and MIC90 values of the tested antibiotics were as follows: cotrimoxazole 0.032 ?g/ml and 0.064 ?g/ml, doxycycline 0.064 ?g/ml and 0.094 ?g/ml, ciprofloxacin 0.094 ?g/ml and 0.75 ?g/ml, streptomycin 0.25 ?g/ml and 0.50 ?g/ml, and rifampin 0.50 ?g/ml and 0.75 ?g/ml, respectively. Doxycycline-rifampin combination showed a remarkable synergistic activity to all tested strains (%100), but rifampin-cotrimoxazole combination exhibited antagonist activity to two strains (5%). The ratios of synergistic activities were as follows: ciprofloxacin-streptomycine 57.5%, rifampin-cotrimoxazole 52.5%, doxycycline-streptomycin 32.5%, and ciprofloxacin-cotrimoxazole 25%. In this study, though cotrimoxazole was the highest in vitro active against to tested strains, its combination showed low synergistic effect with other antimicrobials. On the contrary, though rifampin showed low in vitro activity alone, it exhibited excellent synergistic effect when combined with doxycycline. Therefore, when the treatment is planned for a patient with Brucellosis, it will be benefit for testing the combination effectiveness of the drugs irrespective of their in vitro activities alone.en_US
dc.identifier.citationKAYSADU H,DUMAN Y,YAKUPOĞULLARI Y (2019). nvestigation of Synergistic, Additive and Antagonist Effect of Antimicrobial Combinations Used for Brucella spp, with E-test Combination Method. Eastern Journal of Medicine, 24(1), 95 - 101. Doi: 10.5505/ejm.2019.66588en_US
dc.identifier.doi10.5505/ejm.2019.66588en_US
dc.identifier.endpage101en_US
dc.identifier.issn1301-0883
dc.identifier.issn1339-3886
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85062969210en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage95en_US
dc.identifier.trdizinid326048en_US
dc.identifier.urihttps://doi.org/10.5505/ejm.2019.66588
dc.identifier.urihttps://hdl.handle.net/11616/19120
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/326048
dc.identifier.volume24en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherEastern Journal of Medicineen_US
dc.relation.ispartofEastern Journal of Medicineen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titlenvestigation of Synergistic, Additive and Antagonist Effect of Antimicrobial Combinations Used for Brucella spp, with E-test Combination Methoden_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Makale Dosyası.pdf
Size:
272.15 KB
Format:
Adobe Portable Document Format
Description:
Makale Dosyası
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: